Mental health

AMA Moves to Ban Direct-To-Consumer Pharmaceutical Ads

According to the AMA, direct-to-consumer advertising of pharmaceuticals and medical devices drives up health care costs and should be banned. [More…]

Read More
DETAIL

Diabetes Screening Inadequate in Mentally Ill

New research shows that despite long-standing recommendations that severely mentally ill patients who take antipsychotics undergo annual screening for diabetes and other metabolic disorders, only 30% receive such screening. A recent research letter in JAMA Internal Medicine described a retrospective cohort study that analyzed diabetes screening prevalence and predictors of screening among adults in the California […]

Read More
DETAIL

Americans Say They View Mental and Physical Health As Equally Important

A recent Harris Poll survey about attitudes toward mental health was conducted on behalf of the Anxiety and Depression Associations of America, American Foundation for Suicide Prevention and the National Alliance for Suicide Prevention. Over 2,000 US adults over 18 responded. Results revealed that “ majority (65%) of U.S. adults has seen a primary care […]

Read More
DETAIL

National Academy of Medicine Establishes Standards for Psychosocial Treatments

A new report by the National Academy of Medicine, titled, “Psychosocial Interventions for Mental and Substance Use Disorders: A Framework for Establishing Evidence-Based Standards” highlights the need to strengthen evidence on the effectiveness of psychosocial interventions, and to develop guidelines and quality measures for implementing these interventions in professional practice. Two important pieces of legislation aim […]

Read More
DETAIL

Long-Acting Injectable Antipsychotic To Prevent Relapse in First Episode Schizophrenia

Research published in JAMA Psychiatry demonstrated that long-acting, injectable, second-generation antipsychotic medication has tremendous potential to bring clinical stability to persons with first-episode schizophrenia. According to the authors, “long-acting medications are rarely used following a first episode of schizophrenia.” Patients with recent onset of schizophrenia (n=86) were randomized to receive long-acting injectable risperidone or oral […]

Read More
DETAIL

Prevalence of Mental Disorders in Mid-life and Older Adulthood Greater than Previous Reported

A new study published in JAMA Psychiatry evaluated retrospective and cross-sectional surveys of reported statistics of mental health disorders and compared those results with reports of physical disorders. Interviews of 1071 adults who participated in the Baltimore Epidemiologic Catchment Area Survey which included a series of interviews that spanned a period of 24 years, revealed […]

Read More
DETAIL

White House Conference on Mental Health

This week, the White House organized a conference on mental health with a particular emphasis on stigma and awareness. President Barack Obama opened the conference by calling for a more robust national discussion on mental illness, saying the time had come to bring the issue “out of the shadows.” He added, that his goal was […]

Read More
DETAIL

Essential Components of First-Episode Psychosis Services

A study published in May 1st, 2013 Psychiatric Services identified essential evidence-based components of first-episode psychosis services. The research took place in two stages. First a systematic literature review, then, a consensus-building technique, the Delphi, was used with an international panel of experts. The panelists were presented the evidence-based components identified in the review, together […]

Read More
DETAIL